Symbol search
date o news sym
globenewswire
11:30 Tue 4
Nws
Cytokinetics Announces Cohort 3 of REDWOOD-HCM is Open to Enrollment
Next Cohort to Enroll Patients on Background Therapy of Disopyramide Next Cohort to Enroll Patients on Background Therapy of Disopyramide
https://www.globenewswire.com/news-release/2021/05/04/2222165/35409/en/Cytokinetics-Announces-Cohort-3-of-REDWOOD-HCM-is-Open-to-Enrollment.html
CYTK
Healt
Text search
date o news
@MarketCurrents
13:02 Tue 4
Nws
$CYTK - Cytokinetics' Cohort 3 of REDWOOD-HCM trial is open to enrollment https://t.co/mwt4ttmqL2
-
CYTK
Healt
globenewswire
11:30 Tue 4
Nws
Cytokinetics Announces Cohort 3 of REDWOOD-HCM is Open to Enrollment
Next Cohort to Enroll Patients on Background Therapy of Disopyramide Next Cohort to Enroll Patients on Background Therapy of Disopyramide
CYTK
Healt
prnewswire:443
16:00 Tue 4
NwsFnnc
Vivace Therapeutics announces dosing of first cohort of patients with its first-in-class TEAD inhibitor
SAN MATEO, Calif., May 4, 2021 /PRNewswire/ -- Vivace Therapeutics, Inc., a small molecule discovery and development company developing first-in-class therapies targeting the Hippo pathway, announced today the completion of enrollment of the first cohort of patients being treated with...


prnewswire:443
11:43 Wed 5
Nws
Oncopeptides completes patient enrollment in phase 2 PORT study
STOCKHOLM, May 5, 2021 /PRNewswire/ -- Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announces that the Company has completed patient enrollment in the phase 2 PORT...


globenewswire
11:00 Mon 3
Nws
Cabaletta Bio Reports Acute Safety Data from the First Dose Cohort in DesCAARTes Trial
No dose limiting toxicities (DLTs) or clinically relevant adverse events observed in the first dose cohort as of April 30, 2021


globenewswire
11:05 Mon 3
Nws
Cabaletta Bio Reports First Quarter 2021 Financial Results and Provides New Pipeline Updates
Acute safety data from the first cohort in the DesCAARTes trial announced today; no dose limiting toxicities (DLTs) or clinically relevant adverse events observed in the first dose cohort as of April 30, 2021


forbes
07:54 Tue 4
We Cant Stop: How Union County College Students, Faculty, And Staff Have Refused To Let The COVID-19 Pandemic Defer Their Goals.
Community college enrollment fell again by double digits (11.3%) during the Spring 2021 semester. This decrease in enrollment is alarming for many who find most public and private four-year college costs and admissions requirements unattainable as first-year students...


prnewswire:443
15:00 Mon 3
Nws
BIG3 Announces First-Ever Open Tryouts Prior To Fourth Season
LOS ANGELES, May 3, 2021 /PRNewswire/ -- Today, the BIG3 announced its first-ever open tryouts for the fourth season to be held at Athletic Republic Capitol Region, just south of Washington, D.C. on May 22 and Drive Nation Sports in Dallas, Texas on May 27. Athletes must be 22 years or...


prnewswire:443
10:00 Wed 5
Nws
Parallel Wireless Announces ALL G O-RAN Solution Milestone
An O-RAN compliant solution supporting All Gs 2G, 3G, 4G, and 5G for 7.2 radios in urban and dense urban environments NASHUA, N.H., May 5, 2021 /PRNewswire/ -- Parallel Wireless, Inc., the U.S.-based Open RAN company delivering the world's leading All G, cloud-native Open RAN solution...


globenewswire
13:55 Mon 3
Report on New Mexico Charter Schools Finds Promising Trends in Dual Language Education and College Enrollment
Rockville, Md., May 03, 2021 (GLOBE NEWSWIRE) -- A new report compiling several studies of charter schools in New Mexicoincluding elementary, middle, high, and dual language schoolsobserves some promising trends for college enrollment, amidst other mixed findings. Conducted for Arnold Ventures by Abt Associates, the New Mexico Charter School Study: Findings Report collates the results of Abts evaluation of numerous charter schools in the state, several of which employ a whole-school dual language model. The study also created multiple logic models for use by practitioners, policymakers, and researchers, and led to ideas for making enrollment in charters schools more equitable.


globenewswire
11:00 Tue 4
Nws
Resgreen Group (OTCPINK: RGGI) Announces Testing of Nimble Messaging System for Wanda SD Fleets to Call Home
Clinton Township, Michigan, May 04, 2021 (GLOBE NEWSWIRE) -- Resgreen Group International (OTCPINK: RGGI), a leading mobile robot company, announces testing of an enhanced service to monitor Wanda SD fleets by implementing Open Source MQTT (Message Queuing Telemetry Transport) Broker.


@cnni
20:15 Wed 5
Nws
The Board of Control for Cricket in India will help move Australia's entire IPL 'cohort' to the Maldives or Sri Lan https://t.co/qxtRoYTggH
-


@MarketCurrents
14:47 Tue 4
Nws
$PFE - Enrollment in Pfizer elranatamab trial paused amid cases of peripheral neuropathy https://t.co/jqF628ve7Q
-
PFE
Healt
@MarketCurrents
13:31 Tue 4
Nws
$VXRT - Vaxart starts enrollment in early-stage norovirus boosting regimen study https://t.co/EOKMGb7OcB
-


prnewswire:443
18:59 Wed 5
NwsOffrn
NVR, Inc. Announces Share Repurchase
RESTON, Va., May 5, 2021 /PRNewswire/ -- NVR, Inc. (NYSE: NVR) announced today that its Board of Directors has authorized the repurchase of $500 million of its outstanding common stock. The purchases will occur from time to time in the open market and/or in privately negotiated...
NVR
Consu
abc net au
22:19 Mon 3
Mrkts
Ash Barty beats French Open champion Iga witek to reach Madrid Open quarters
Ash Barty's run of form continues, with the Australian defeating her successor as French Open champion in Madrid to extend herwinning streak on red clay to 14 matches.


@Forbes
23:28 Wed 5
Nws
Here are 5 college application and enrollment trends to watch for in fall 2021: https://t.co/hS8XgjJp8F Via https://t.co/ijitXpB6NV
-


proactiveinvestors
20:48 Wed 5
TRACON Pharmaceuticals ends 1Q with $30.4M to fund its cancer drug trials
TRACON Pharmaceuticals Inc (NASDAQ:TCON) ended the first quarter of 2021 on March 31 with cash and equivalents of $30.4 million, which it said will fund its operations into the second half of 2022. The company also noted that as of May 5, it has initiated 22 US clinical sites and enrolled more than 20 patients in the pivotal ENVASARC trial of single-agent envafolimab and envafolimab combined with Yervoy, which has triggered the initial Data Monitoring Committee review of safety data from each cohort. We continue to be pleased with the pace of enrollment in the pivotal ENVASARC trial and remain on track to deliver interim data in the second half of this year and final data in 2022, CEO Dr Charles Theuer said in a statement. READ: TRACON Pharmaceuticals driving the development of targeted therapies for cancer via collaborations We have now initiated 22 sites and have enrolled more than 20 patients which has triggered the initial Data Monitoring Committee review of safety data from each cohort, which we expect later this quarter, Dr Theuer added. In April, TRACON resubmitted its Orphan Drug Designation application to the US Food and Drug Administration (FDA) in response to a request for preclinical or clinical evidence of activity for its clinical-stage drug envafolimab for treating sarcoma. It expects correspondence from the FDA this quarter based on the amended application. The company also outlined some other key upcoming milestones, including: Orphan Drug Designation for envafolimab in soft tissue sarcoma from the FDA in 1H 2021 Independent Data Monitoring Committee review of ENVASARC safety data in 1H 2021 American Society of Clinical Oncology (ASCO) presentation of ENVASARC pivotal trial design in 1H 2021 ASCO presentation of TJ004309 Phase 1 data in 1H 2021 Interim ENVASARC efficacy and safety data in 2H 2021 Request FDA breakthrough therapy designation or Fast Track designation for envafolimab in 2H 2021 Decision on the envafolimab New Drug Application (NDA) in MSI-H/dMMR cancer that is under priority review by the Chinese National Medical Products Administration (NMPA) TRACON has positioned itself as a collaboration partner that leads the regulatory filings, clinical trials, as well as US commercialization of best-in-class drug candidates, as an alternative to expensive contract research organization (CRO) based development. Contact Sean at sean@proactiveinvestors.com
TCON
Healt
upi
15:28 Mon 3
Nws
Israel announces investigation into deadly stampede that killed 45
Israeli officials said Monday they will open a special investigation into a deadly stampede last week during a religious event on Mount Meron that killed 45 people, including a 19-year-old American man.


prnewswire:443
11:00 Mon 3
NwsOffrn
Taboola Announces Filing of Registration Statement on Form F-4 in Connection With Its Proposed Business Combination with ION Acquisition Corp. 1 Ltd.
NEW YORK, May 3, 2021 /PRNewswire/ -- Taboola, a global leader in powering recommendations for the open web, helping people discover things they may like, today announced it has filed with the U.S. Securities and Exchange Commission ('SEC') a registration statement on Form F-4 (the...


globenewswire
10:30 Tue 4
NwsFnnc
Shopify Joins the Open Invention Network
DURHAM, N.C., May 04, 2021 (GLOBE NEWSWIRE) -- Open Invention Network (OIN), the largest patent non-aggression community in history, announced today that Shopify has become a licensee and community member of OIN. As a leading global commerce platform providing trusted tools to start, grow, market, and manage a retail business of any size, Shopify is reinforcing its commitment to open source software (OSS) as an enabler of its growing business.


news google au
19:40 Mon 3
Nws
Ashleigh Barty vs. Iga Swiatek | 2021 Madrid Round of 16 | WTA Match Highlights - WTA
Ashleigh Barty vs. Iga Swiatek | 2021 Madrid Round of 16 | WTA Match Highlights    WTA Ash Barty shows French Open champion whos boss, extends incredible hot streak    NEWS.com.au Ash Barty beats fellow French Open champ Iga Swiatek at Madrid Open to reach quarters    Wide World of Sports Barty into Madrid Open quarter finals    inverelltimes.com.au Ash Barty extends her winning streak on red clay to 14 matches, beating Iga witek to reach Madrid Open last eight    ABC News View Full coverage on Google News


globenewswire
10:30 Tue 4
Nws
Jounce Therapeutics Reports First Quarter 2021 Financial Results
- Enrollment on track in both the Phase 1 INNATE trial of JTX-8064 (LILRB2 / ILT4) and the biomarker selected Phase 2 SELECT trial of Vopratelimab in combination with Pimivalimab -
JNCE
Healt
prnewswire:443
22:55 Mon 3
Nws
Underdog Fantasy Announces Fundraise and $3,500,000 Best Ball Tournament
BROOKLYN, N.Y., May 3, 2021 /PRNewswire/ -- Today, Underdog Fantasy, the fastest growing fantasy app ever, is announcing the largest season long fantasy payout ever. A $3.5m season long NFL Best Ball tournament, with $1,000,001 to first place, Best Ball Mania II is now open for entry....


forbes
22:27 Tue 4
Americas Hidden Education Tragedy
While school enrollment numbers across the United States have steadily tumbled in response to Covid-19, some large cities, such as Chicago, experienced declining numbers well before the pandemic. A new film looks behind the scenes at an iconic American city to reveal the real battle.


prnewswire:443
10:00 Tue 4
Caspar.Ai Granted Additional U.S. Patent For Artificial Intelligence Applications
SAN FRANCISCO, May 4, 2021 /PRNewswire/ -- The United States Patent Office has granted additional patent to BrainofT, Inc., Redwood City, CA d/b/a Caspar.AI. The announcement was made by Caspar.AI CEO and Co-Founder, Dr. Ashutosh Saxena and Dr. David Cheriton, Caspar.AI Chief Scientist...


prnewswire:443
19:26 Mon 3
NwsFnnc
Arkad S.p.A. Selects Ivalua & PwC To Drive Its Procurement Tranformation Journey
REDWOOD CITY, Calif., May 3, 2021 /PRNewswire/ -- Ivalua, a leading global spend management cloud provider, and PwC, a trusted Ivalua implementation partner, today announced that Arkad S.p.A. has selected Ivalua's platform to drive its Procurement digital transformation journey with PwC...


globenewswire
20:05 Tue 4
NwsFnnc
Seer to Present at the BofA Securities 2021 Healthcare Conference
REDWOOD CITY, Calif., May 04, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced it will be participating virtually in the upcoming BofA Securities 2021 Healthcare Conference.


@BBCNews
06:39 Wed 5
GnrlHdgFn
RT @BBCBreakfast: We open the curtains and decide whether we are open or not Pub manager Steve Harvey tells #BBCBreakfast the weather me
-


globenewswire
07:35 Wed 5
Nws
CytoDyn Reaches Agreement with Albert Einstein Israelite Hospital in Brazil to Conduct Two COVID-19 Trials - a Small Trial in Critically Ill and a Large Trial in Severe Populations
Interim analysis for critically ill population will be conducted when enrollment reaches about 120 patients or 40% of the approximate 300 patients
CYDY
Healt